SEC Filing Record

Offering Amount

$1.0M

Strategy

VC

Exemption

06b

Date Filed

Jun 09, 2026

0002139598-26-000001

View on SEC EDGAR →

37A Read

The series structure—a single Series under an LLC umbrella with two named GPs—indicates a lean, co-GP model rather than a traditional fund with a single GP entity, which typically allows for faster decision-making but requires clear GP-to-GP alignment on capital deployment and carry allocation.

With no prior EDGAR filings from either Seed Labs LLC or Shriank Kanaparti, this is a first institutional fund raise from these managers, meaning LPs are evaluating founders or operators transitioning into venture deployment rather than reviewing an established fund series evolution or track record.

A $1M target filed in June 2026 during a period of venture market recalibration signals either a micro-fund strategy targeting angel-round or pre-seed cheques, a placeholder filing intended to close before year-end LP allocation cycles lock, or a test raise to validate LP appetite before pursuing a larger vehicle.

Verify whether Seed Labs LLC is an operating entity with deal experience or a newly formed GP entity, and confirm the carried interest waterfall and GP commitment levels between the two named GPs—the co-GP structure creates ambiguity around decision rights and fee/carry splits that can affect execution speed in follow-ons.

Full analysis (GP structure, exemption breakdown, and market context) is available to Pro members.

Unlock Pro · $29/month → Sign in

Principals

General Partners & Executives

Seed Labs LLC Shriank Kanaparti

KP Group I a Series of SLRTE I LLC